TG Therapeutics’ CEO Sees Global Revenue Exceeding $1B In 2026 – BRIUMVI Drives Q3 Topline Beat
TG Therapeutics reported Q3 revenue of $259.9 million, beating Wall Street’s estimate of $245.5 million, according to Fiscal.ai.
TG Therapeutics reported Q3 revenue of $259.9 million, beating Wall Street’s estimate of $245.5 million, according to Fiscal.ai.